Abstract
Down syndrome (DS) is the most common chromosomal disorder and the leading genetic cause of intellectual disability in humans, which results from the triplication of chromosome 21. DS individuals have an increased risk of developing Alzheimer's disease (AD)-like pathology and dementia by the age of 40 due to the triplication of several genes involved in the formation of amyloid plaques and tau tangles. Further, DS and AD are characterized by the aberrant accumulation of unfolded/misfolded proteins resulting from over-burdened protein quality control systems. The accumulation of misfolded proteins in the endoplasmic reticulum (ER) triggers a cellular stress response called the unfolded protein response (UPR). Long-term activation of the UPR mediates neuronal dysfunction in AD. We hypothesized that the UPR is impacted in a mouse model of DS. To test this, we performed gene and protein expression analysis of ER stress markers in the Ts65Dn mouse model of DS at 3, 9, and 18 months. We identified activation of the PERK pathway in Ts65Dn DS mice at 3 months of age compared to euploid controls. We also determined that the early and overt UPR activation decreased with age, the UPR signal was significantly reduced by 18 months. Our data suggest that UPR activation in DS mouse models occurs early before consistent brain neurodegeneration and might be an essential contributor to dys-proteostasis.
Original language | English |
---|---|
Pages (from-to) | 347-359 |
Number of pages | 13 |
Journal | Journal of Alzheimer's Disease |
Volume | 62 |
Issue number | 1 |
DOIs | |
State | Published - 2018 |
Bibliographical note
Publisher Copyright:© 2018-IOS Press and the authors. All rights reserved.
Funding
We acknowledge the University of Kentucky Alzheimer’s Disease Center (UK-ADC), which is supported by NIH/NIA P30 AG028383, and the University of Kentucky Microscopy Core, which is supported by NIH/NINDS P30NS051220. JFA, SNF, AI, RAC. SEM, EM, DL, and GKN, were supported by NIH/NINDS 1R01 NS091329-01, Alzheimer’s Association NIRG-14-322441, NIH/NCATS 5UL1 TR000117-04, NIH/NIGMS 5P30GM110787, Department of Defense AZ140097, the University of Kentucky Epilepsy Center (EpiC), NIH/NIA P30 AG028383, NIH/NIMHD L32 MD009205-01 and NIH/NICHHD R01HD064993. This work was also supported by Fondi di Ateneo and SIR program of the Italian Ministry of Education, University and Research (RBSI144MTL) to F.D.D.
Funders | Funder number |
---|---|
Fondi Ateneo | |
NICHHD | R01HD064993 |
University of Kentucky Alzheimer’s Disease Research Center | |
University of Kentucky Epilepsy Research Center | |
National Institutes of Health (NIH) | |
U.S. Department of Defense | AZ140097 |
National Institute on Aging | P30 AG028383 |
National Institute of General Medical Sciences | 5P30GM110787 |
Institute of Neurological Disorders and Stroke National Advisory Neurological Disorders and Stroke Council | R21NS094918, P30NS051220 |
Alzheimer's Association | NIRG-14-322441 |
National Center for Advancing Translational Sciences (NCATS) | 5UL1 TR000117-04 |
National Institute on Minority Health and Health Disparities (NIMHD) | L32 MD009205-01 |
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung | 1R01 NS091329-01 |
Ministero dell’Istruzione, dell’Università e della Ricerca | RBSI144MTL |
Keywords
- Down syndrome
- PERK
- Ts65Dn
- eif2 alpha
- unfolded protein response
ASJC Scopus subject areas
- General Neuroscience
- Clinical Psychology
- Geriatrics and Gerontology
- Psychiatry and Mental health